Noom Expands Digital Health Offerings with GLP-1 Support and AI Coaching

WIRED has reported that Noom is offering promotional codes and free trials for its weight loss and GLP-1 medication support services in July 2026. The company, which was founded in 2008 as a human-to-human weight loss coaching service, has expanded its model to include support for users taking GLP-1 medications such as WeGovy, Ozempic, and Zepbound, as well as those undergoing hormone replacement therapy.

The platform combines its original psychology-based methods with fitness and food tracking, now integrating AI coaching and medical supervision into its plans. New features include a dedicated GLP-1 AI companion designed to provide personalised protein and hydration guidance, alongside workouts intended to help preserve muscle mass.

Pricing structures vary depending on the specific plan chosen. The Noom Microdose GLP-1 program, which offers a lower starting dose to minimise side effects, starts at $79 for an initial three-week subscription, or $199 per month for a 12-week subscription. Standard GLP-1 medication access starts at $99 regardless of insurance, with specific medications like Zepbound and Ozempic available starting at $69.

For standard weight loss, the 12-month plan costs $17.42 per month following a free week-long trial. Plans are automatically renewed and billed up-front, with promo codes available to offset costs. The availability of specific discounts and free trials may vary depending on whether a user selects the Noom Weight or Noom Med plan.

Noom’s expansion into medical supervision reflects a broader shift in digital health, where technology platforms are increasingly facilitating access to prescription treatments. The company’s approach pairs medication with habit tracking and coaching, aiming to support sustainable lifestyle changes for users managing weight or hormonal transitions.